Budget Impact & Cost-effectiveness Models & Studies

The main driver of decisions (inclusion in formularies, negotiation of price discounts) at the country level is the budget impact of introducing a new drug. Although healthcare payers are looking at the benefit over next best treatment alternative, they also focus on the impact it will have on their health care budget. Again, CCHO HEOR experts have been at the heart of national and regional Market Access strategy by providing models of cost effectiveness and budgetary impact